EVALUATION OF CYTOTOXIC ACTIVITY OF CANAGLIFLOZIN IN HEPG2 CELL LINES. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 9, p. 1723–1727, 2024. DOI: 10.53555/461ss311. Disponível em: https://jptcp.com/index.php/jptcp/article/view/7997. Acesso em: 28 sep. 2024.